NP Life Sciences Health Industry Group Inc. (ACAT)
About NP Life Sciences Health Industry Group Inc.
ACASIA TECH INC A
This profile is unclaimed. An authorized representative can claim it free to control the page and activate the embeddable Verified badge.
Financial summary
- Revenue FY2023
- $164.6K
- Net income
- -$2.9K
- Total assets
- $76.9K
Source: SEC EDGAR · updated Jun 8, 2026
- Dividend yield
- 5.0%
- Open
- —
- Day range
- –
- Prev close
- —
- Volume
- —
NP Life Sciences Health Industry Group Inc. (ACAT) Stock Price
- Reported a net loss of $2.9K in FY2023.
- Trading near its 52-week high.
- Pays a dividend yielding about 5.0% annually.
Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.
No reviews yet. Be the first to review NP Life Sciences Health Industry Group Inc..
Write a review
NP Life Sciences Health Industry Group Inc.: frequently asked questions
Is NP Life Sciences Health Industry Group Inc. an American company?
NP Life Sciences Health Industry Group Inc. is a US-based company headquartered in Danville, California, listed in the americancompanies.com directory of American companies. Its American-origin credentials have not yet been independently verified.
Where is NP Life Sciences Health Industry Group Inc. headquartered?
NP Life Sciences Health Industry Group Inc. is headquartered in Danville, California, United States.
Is NP Life Sciences Health Industry Group Inc. publicly traded?
Yes — NP Life Sciences Health Industry Group Inc. is a publicly traded company. Its stock trades under the ticker symbol ACAT on the OTC.
